原发性肝癌67例介入治疗分析

Analysis of interventional therapy for primary liver cancer in 67 cases

目的探讨原发性肝癌的灌注化疗加栓塞治疗的临床疗效。方法收集该院67例原发性肝癌患者,采用灌注化疗加栓塞治疗进行治疗,均采用Seldinger技术,经皮股动脉穿刺插管。结果全组2、4、6、8、12和24个月生存率分别为95.52%、92.53%、77.61%、65.67%、50.75%和16.41%。结论采用灌注化疗加栓塞治疗进行治疗,对提高肝癌患者近期治疗效果及延长生存期具有重要作用。

[Objective] To evaluate the effect of transcatheter hepatic arterial chemoemhlization （FACE） in primary hepatic cellular carcinoma （HCC）. [Method] TACE was performed in 67 patients with middle and advanced stages of hepatic carcinoma via femoral artery catheterization with Seldinger＇s technique. [Result] The survival rate of 2, 4, 6, 8, 12, and 24 month were 95.52%, 92.53%, 77.61%, 65.67%, 50.75%, 16.41%. [Conclusion] TACE was an effective method for hepatic carcinoma in middle and advanced stages.